Back

NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.

Sell

NBY
NovaBay Pharmaceuticals

Last Price:

0.08

Seasonality Move:

-8.08%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

NovaBay Pharmaceuticals Price Quote

$0.08

+0.00 (+3.9%)

(Updated: April 27, 2024 at 6:13 AM ET)

NovaBay Pharmaceuticals Key Stats

Sell

NovaBay Pharmaceuticals (NBY) is a Sell

Day range:

$0.08 - $0.09

52-week range:

$0.07 - $1.28

Dividend yield:

P/E ratio:

0.00

P/S ratio:

0.03

P/B ratio:

1.74%

Volume:

2.5M

Avg. volume:

2.6M

1-year change:

-94.23%

Market cap:

$2.4M

Revenue:

$14.7M

EPS:

$-3.31

How Much Does NovaBay Pharmaceuticals Make?

How Much Are NovaBay Pharmaceuticals's Sales Annually?
NBY Revenues are $14.7M
How Much Profit Does NovaBay Pharmaceuticals's Make A Year?
NBY net income is -$9.6M

Is NovaBay Pharmaceuticals Growing As A Company?

What Is NovaBay Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02%
What Is NovaBay Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

NovaBay Pharmaceuticals Stock Price Performance

Did NovaBay Pharmaceuticals Stock Go Up Last Month?
NovaBay Pharmaceuticals share price went down by -43.31% last month
Did NBY's Share Price Rise Over The Last Year?
NBY share price fell by -94.23% over the past 1 year

What Is NovaBay Pharmaceuticals 52-Week High & Low?

What Is NovaBay Pharmaceuticals’s 52-Week High Share Price?
NovaBay Pharmaceuticals has traded as high as $1.28 over the past 52 weeks
What Is NovaBay Pharmaceuticals’s 52-Week Low Share Price?
NovaBay Pharmaceuticals has traded as low as $0.07 over the past 52 weeks

NovaBay Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NovaBay Pharmaceuticals?

How Much Debt Does NovaBay Pharmaceuticals Have?
Total long term debt quarterly is $1.1M
How Much Cash Does NovaBay Pharmaceuticals Have?
Cash and short term investments quarterly total is $3.1M
What Is NovaBay Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.12

Is NovaBay Pharmaceuticals Cash Flow Positive?

What Is NBY Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.1M
What Is NovaBay Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.9M
What Is NovaBay Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19K

NovaBay Pharmaceuticals Return On Invested Capital

Is Management Doing A Good Job?
NBY return on invested capital is -114.9%
What Is NovaBay Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -69.74%
What Is NBY Return On Equity?
ROE is a measure of profitability and is -125.66%

NovaBay Pharmaceuticals Earnings Date & Stock Price

What Is NovaBay Pharmaceuticals's Stock Price Today?
A single share of NBY can be purchased today for 0.08
What Is NovaBay Pharmaceuticals’s Stock Symbol?
NovaBay Pharmaceuticals trades on the nyam under the ticker symbol: NBY
When Is NovaBay Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NovaBay Pharmaceuticals is scheduled on April 28, 2024
When Is NBY's next ex-dividend date?
NovaBay Pharmaceuticals's next ex-dividend date is April 28, 2024
How To Buy NovaBay Pharmaceuticals Stock?
You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

NovaBay Pharmaceuticals Competitors

Who Are NovaBay Pharmaceuticals's Competitors?
Below is a list of companies who compete with NovaBay Pharmaceuticals or are related in some way:
- Eyenovia Inc (EYEN)
- iBio Inc (IBIO)
- Oragenics Inc (OGEN)
- Palatin Technologies Inc (PTN)
- Theriva Biologics Inc (TOVX)

NovaBay Pharmaceuticals Dividend Yield